Efficacy and Safety of Obinutuzumab in Immune‐Mediated Thrombotic Thrombocytopenic Purpura
(se abrirá en una nueva ventana)
Autores:
Julia Weisinger, Raïda Bouzid, Jehane Fadlallah, Christelle Barbet, Francois Provot, Pascale Poullin, Antoine Neel, Manon Marie, Virginie Rieu, Tarik Kanouni, Olivier Moranne, Elie Azoulay, Zora Marjanovic, Elise Corre, Anne‐Christine Joly, Minh‐Tam Baylatry, Bérangère S. Joly, Agnes Veyradier, Paul Coppo, null null
Publicado en:
American Journal of Hematology, Edición 100, 2025, ISSN 0361-8609
Editor:
Wiley
DOI:
10.1002/AJH.27550
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes
(se abrirá en una nueva ventana)
Autores:
Ivan Garcia-Loza, David Perna-Barrull, Eva Aguilera, Lidia Almenara-Fuentes, Laia Gomez-Muñoz, Daniela Greco, Maria Vila, Miriam Salvado, Montserrat Mancera-Arteu, Michael W. Olszowy, Jordi Petriz, Marti Dalmases, Silvia Rodriguez-Vidal, Bruna Barneda-Zahonero, Marta Vives-Pi
Publicado en:
Journal of Autoimmunity, Edición 145, 2024, ISSN 0896-8411
Editor:
Elsevier BV
DOI:
10.1016/J.JAUT.2024.103196
Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura
(se abrirá en una nueva ventana)
Autores:
Julia Weisinger, Raïda Bouzid, Dana Ranta, Pascal Woaye‐Hune, Fleur Cohen‐Aubart, Clotilde Gaible, Zora Marjanovic, Elise Corre, Anne‐Christine Joly, Minh‐Tam Baylatry, Berangère S. Joly, Agnès Veyradier, Paul Coppo
Publicado en:
British Journal of Haematology, Edición 205, 2024, ISSN 0007-1048
Editor:
Wiley
DOI:
10.1111/BJH.19752